tetano
Editor, Senior Moderator
Sci Data. 2020 Mar 24;7(1):106. doi: 10.1038/s41597-020-0448-0.
Epidemiological data from the COVID-19 outbreak, real-time case information.
Xu B[SUP]1,[/SUP][SUP]2[/SUP], Gutierrez B[SUP]2,[/SUP][SUP]3[/SUP], Mekaru S[SUP]4,[/SUP][SUP]5[/SUP], Sewalk K[SUP]4[/SUP], Goodwin L[SUP]4[/SUP], Loskill A[SUP]4,[/SUP][SUP]6[/SUP], Cohn EL[SUP]4[/SUP], Hswen Y[SUP]4[/SUP], Hill SC[SUP]2[/SUP], Cobo MM[SUP]3,[/SUP][SUP]7[/SUP], Zarebski AE[SUP]8[/SUP], Li S[SUP]2,[/SUP][SUP]9[/SUP], Wu CH[SUP]10[/SUP], Hulland E[SUP]11,[/SUP][SUP]12[/SUP], Morgan JD[SUP]11,[/SUP][SUP]12[/SUP], Wang L[SUP]13,[/SUP][SUP]14[/SUP], O'Brien K[SUP]4[/SUP], Scarpino SV[SUP]15[/SUP], Brownstein JS[SUP]4,[/SUP][SUP]16[/SUP], Pybus OG[SUP]2[/SUP], Pigott DM[SUP]17,[/SUP][SUP]18[/SUP], Kraemer MUG[SUP]19,[/SUP][SUP]20,[/SUP][SUP]21[/SUP].
Author information
Abstract
Cases of a novel coronavirus were first reported in Wuhan, Hubei province, China, in December 2019 and have since spread across the world. Epidemiological studies have indicated human-to-human transmission in China and elsewhere. To aid the analysis and tracking of the COVID-19 epidemic we collected and curated individual-level data from national, provincial, and municipal health reports, as well as additional information from online reports. All data are geo-coded and, where available, include symptoms, key dates (date of onset, admission, and confirmation), and travel history. The generation of detailed, real-time, and robust data for emerging disease outbreaks is important and can help to generate robust evidence that will support and inform public health decision making.
PMID:32210236DOI:10.1038/s41597-020-0448-0
Epidemiological data from the COVID-19 outbreak, real-time case information.
Xu B[SUP]1,[/SUP][SUP]2[/SUP], Gutierrez B[SUP]2,[/SUP][SUP]3[/SUP], Mekaru S[SUP]4,[/SUP][SUP]5[/SUP], Sewalk K[SUP]4[/SUP], Goodwin L[SUP]4[/SUP], Loskill A[SUP]4,[/SUP][SUP]6[/SUP], Cohn EL[SUP]4[/SUP], Hswen Y[SUP]4[/SUP], Hill SC[SUP]2[/SUP], Cobo MM[SUP]3,[/SUP][SUP]7[/SUP], Zarebski AE[SUP]8[/SUP], Li S[SUP]2,[/SUP][SUP]9[/SUP], Wu CH[SUP]10[/SUP], Hulland E[SUP]11,[/SUP][SUP]12[/SUP], Morgan JD[SUP]11,[/SUP][SUP]12[/SUP], Wang L[SUP]13,[/SUP][SUP]14[/SUP], O'Brien K[SUP]4[/SUP], Scarpino SV[SUP]15[/SUP], Brownstein JS[SUP]4,[/SUP][SUP]16[/SUP], Pybus OG[SUP]2[/SUP], Pigott DM[SUP]17,[/SUP][SUP]18[/SUP], Kraemer MUG[SUP]19,[/SUP][SUP]20,[/SUP][SUP]21[/SUP].
Author information
Abstract
Cases of a novel coronavirus were first reported in Wuhan, Hubei province, China, in December 2019 and have since spread across the world. Epidemiological studies have indicated human-to-human transmission in China and elsewhere. To aid the analysis and tracking of the COVID-19 epidemic we collected and curated individual-level data from national, provincial, and municipal health reports, as well as additional information from online reports. All data are geo-coded and, where available, include symptoms, key dates (date of onset, admission, and confirmation), and travel history. The generation of detailed, real-time, and robust data for emerging disease outbreaks is important and can help to generate robust evidence that will support and inform public health decision making.
PMID:32210236DOI:10.1038/s41597-020-0448-0